Other studies reported a decrease in CD8 MAIT cell frequency in relapsing remitting (222, 223) and primary progressive MS (224, 225) or no differences between MS patients and healthy donors in MAIT frequency, phenotype and activation potential (226). The gene discussed is CD8A; the disease is myeloid sarcoma.